Immunization, Hib3 in Other small states
Other small states: Immunization, Hib3 was 85.6% in 2024. ◆ Volatile
Immunization, Hib3 in Other small states, 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Other small states is 85.6%, measured in 2024.
That represents a change of down 0.1% on the previous year and down 4.5% over ten years.
Over the whole period, immunization, hib3 in Other small states peaked at 89.9% in 2013 and was at its lowest, 0.0%, in 1990.
Other small states ranks 18th of 43 groups on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 in Other small states, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 2.7% | — |
| 1992 | 2.5% | -10.0% |
| 1993 | 2.5% | +0.4% |
| 1994 | 2.5% | +2.8% |
| 1995 | 2.6% | +0.8% |
| 1996 | 3.6% | +39.9% |
| 1997 | 4.3% | +20.9% |
| 1998 | 5.0% | +15.6% |
| 1999 | 5.1% | +1.0% |
| 2000 | 7.5% | +48.3% |
| 2001 | 7.0% | -7.0% |
| 2002 | 8.9% | +27.3% |
| 2003 | 10.2% | +14.9% |
| 2004 | 12.0% | +17.3% |
| 2005 | 12.7% | +5.9% |
| 2006 | 29.5% | +131.9% |
| 2007 | 32.3% | +9.6% |
| 2008 | 39.8% | +23.4% |
| 2009 | 56.9% | +43.0% |
| 2010 | 63.9% | +12.2% |
| 2011 | 69.3% | +8.5% |
| 2012 | 75.1% | +8.4% |
| 2013 | 89.9% | +19.6% |
| 2014 | 89.6% | -0.3% |
| 2015 | 89.0% | -0.7% |
| 2016 | 86.9% | -2.3% |
| 2017 | 88.7% | +2.1% |
| 2018 | 89.4% | +0.8% |
| 2019 | 89.1% | -0.4% |
| 2020 | 85.6% | -3.8% |
| 2021 | 83.0% | -3.1% |
| 2022 | 86.4% | +4.0% |
| 2023 | 85.7% | -0.8% |
| 2024 | 85.6% | -0.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 3.1% | 0.0% | 5.1% | 10 |
| 2000s | 21.7% | 7.0% | 56.9% | 10 |
| 2010s | 83.1% | 63.9% | 89.9% | 10 |
| 2020s | 85.3% | 83.0% | 86.4% | 5 |
Countries ranked near Other small states
More health data for Other small states
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.96 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0421 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 1.66 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0368 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate 1.62 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.0423 units per person (2025)
- Population ages 25-29, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Other small states?
- Immunization, hib3 in Other small states was 85.6% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Other small states?
- The highest recorded value was 89.9% in 2013.
- What is the lowest immunization, hib3 recorded in Other small states?
- The lowest recorded value was 0.0% in 1990.
- How does Other small states rank for immunization, hib3?
- Other small states ranks 18th out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in Other small states?
- Over the last ten years it is down 4.5%. The long-run trend across the full record is volatile.
- Where does this Other small states data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.